Clinical effectiveness and cost-effectiveness of growth hormone in adults in relation to impact on quality of life: a systematic review and economic evaluation.
Bryant
J
J
Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, UK.
Loveman
E
E
Chase
D
D
Mihaylova
B
B
Cave
C
C
Gerard
K
K
Milne
R
R
D000328:Adult; D003362:Cost-Benefit Analysis; D004393:Dwarfism, Pituitary / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology / Q000523:psychology; D013006:Growth Hormone / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D011788:Quality of Life; D016896:Treatment Outcome
D013006:Growth Hormone